SCOT RICHARD MENTE

Person

ARLINGTON, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Amino-substituted heteroaryls for treating cancers with EGFR mutations
- Patent number 12,037,346
- Issue date Jul 16, 2024
- Nuvalent, Inc.
- Kristin Lynne Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 11,964,961
- Issue date Apr 23, 2024
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic macrocyclic ether chemotherapeutic agents
- Patent number 11,667,649
- Issue date Jun 6, 2023
- Nuvalent, Inc.
- Joshua Courtney Horan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 11,014,909
- Issue date May 25, 2021
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,696,658
- Issue date Jun 30, 2020
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methyl- and trifluromethyl-substituted pyrrolopyridine modulators o...
- Patent number 10,426,135
- Issue date Oct 1, 2019
- Pfizer Inc.
- Mark Edward Schnute
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,421,744
- Issue date Sep 24, 2019
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide-substituted indole modulators of RORC2 and methods of u...
- Patent number 10,385,036
- Issue date Aug 20, 2019
- Pfizer Inc.
- Mark Edward Schnute
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methyoxy-substituted pyrrolopyridine modulators of RORC2 and method...
- Patent number 10,336,748
- Issue date Jul 2, 2019
- Pfizer Inc.
- Mark Edward Schnute
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroarylphenoxy benzamide kappa opioid ligands
- Patent number 10,316,021
- Issue date Jun 11, 2019
- Pfizer Inc.
- Natasha Mariam Kablaoui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators...
- Patent number 10,227,346
- Issue date Mar 12, 2019
- Pfizer Inc.
- Mark Edward Schnute
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,093,655
- Issue date Oct 9, 2018
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,077,272
- Issue date Sep 18, 2018
- Pfizer Inc.
- David Lawrence Firman Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,868,744
- Issue date Jan 16, 2018
- Pfizer Inc.
- David Lawrence Firman Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,856,263
- Issue date Jan 2, 2018
- Pfizer Inc.
- David Lawrence Firman Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,822,097
- Issue date Nov 21, 2017
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,688,698
- Issue date Jun 27, 2017
- Pfizer Inc.
- David Lawrence Firman Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators...
- Patent number 9,670,201
- Issue date Jun 6, 2017
- Pfizer Inc.
- Mark Edward Schnute
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,617,275
- Issue date Apr 11, 2017
- Pfizer Inc.
- Jotham Wadsworth Coe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,527,831
- Issue date Dec 27, 2016
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,527,843
- Issue date Dec 27, 2016
- Pfizer Inc.
- Jennifer Elizabeth Davoren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,139,561
- Issue date Sep 22, 2015
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,133,190
- Issue date Sep 15, 2015
- Pfizer Inc.
- Jennifer Elizabeth Davoren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,107,923
- Issue date Aug 18, 2015
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 8,822,494
- Issue date Sep 2, 2014
- Pfizer Inc.
- Jennifer Elizabeth Davoren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused pyridine compounds as casein kinase inhibitors
- Patent number 8,536,164
- Issue date Sep 17, 2013
- Pfizer Inc.
- Todd W. Butler
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
AMINO-SUBSTITUTED HETEROCYCLES FOR TREATING CANCERS WITH EGFR MUTAT...
- Publication number 20240327435
- Publication date Oct 3, 2024
- Nuvalent, Inc.
- Kristin Lynne Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20240317713
- Publication date Sep 26, 2024
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS
- Publication number 20230076627
- Publication date Mar 9, 2023
- Nuvalent, Inc.
- Joshua Courtney Horan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINO-SUBSTITUTED HETEROCYCLES FOR TREATING CANCERS WITH EGFR MUTAT...
- Publication number 20220363696
- Publication date Nov 17, 2022
- Nuvalent, Inc.
- Kristin Lynne Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS
- Publication number 20220340586
- Publication date Oct 27, 2022
- Nuvalent, Inc.
- Joshua Courtney Horan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS
- Publication number 20220098212
- Publication date Mar 31, 2022
- Nuvalent, Inc.
- Joshua Courtney Horan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20210300899
- Publication date Sep 30, 2021
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20200283407
- Publication date Sep 10, 2020
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RORC2 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20200039960
- Publication date Feb 6, 2020
- Pfizer Inc.
- Mark Edward Schnute
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methyl- and Trifluromethyl-Substituted Pyrrolopyridine Modulators o...
- Publication number 20190387710
- Publication date Dec 26, 2019
- Pfizer Inc.
- Mark Edward Schnute
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20190367485
- Publication date Dec 5, 2019
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methyl- and Trifluromethyl-Substituted Pyrrolopyridine Modulators o...
- Publication number 20190150401
- Publication date May 23, 2019
- Pfizer Inc.
- Mark Edward Schnute
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
RORC2 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20190144429
- Publication date May 16, 2019
- Pfizer Inc.
- Mark Edward Schnute
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20190002439
- Publication date Jan 3, 2019
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20180346477
- Publication date Dec 6, 2018
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RORC2 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20180282304
- Publication date Oct 4, 2018
- Pfizer Inc.
- Mark Edward Schnute
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sulfonamide-Substituted Indole Modulators of RORC2 and Methods of U...
- Publication number 20180273504
- Publication date Sep 27, 2018
- Pfizer Inc.
- Mark Edward Schnute
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20180200253
- Publication date Jul 19, 2018
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methyl- and Trifluoromethyl-Substituted Pyrrolopyridine Modulators...
- Publication number 20180170928
- Publication date Jun 21, 2018
- Pfizer Inc.
- MARK EDWARD SCHNUTE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYLPHENOXY BENZAMIDE KAPPA OPIOID LIGANDS
- Publication number 20180148432
- Publication date May 31, 2018
- Pfizer Inc.
- Natasha Mariam Kablaoui
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RORC2 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20180086736
- Publication date Mar 29, 2018
- Pfizer Inc.
- Mark Edward Schnute
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20180072750
- Publication date Mar 15, 2018
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20180037571
- Publication date Feb 8, 2018
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methyoxy-Substituted Pyrrolopyridine Modulators of RORC2 and Method...
- Publication number 20180002330
- Publication date Jan 4, 2018
- Pfizer Inc.
- Mark Edward Schnute
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methyl- and Trifluoromethyl-Substituted Pyrrolopyridine Modulators...
- Publication number 20170233390
- Publication date Aug 17, 2017
- Pfizer Inc.
- MARK EDWARD SCHNUTE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RORC2 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20170233371
- Publication date Aug 17, 2017
- Pfizer Inc.
- Mark Edward Schnute
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20170165270
- Publication date Jun 15, 2017
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20170057947
- Publication date Mar 2, 2017
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20170037053
- Publication date Feb 9, 2017
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20170037049
- Publication date Feb 9, 2017
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY

SCOT RICHARD MENTE

Person

Patents Grantslast 30 patents

Amino-substituted heteroaryls for treating cancers with EGFR mutations

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic macrocyclic ether chemotherapeutic agents

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Methyl- and trifluromethyl-substituted pyrrolopyridine modulators o...

Heteroaromatic compounds and their use as dopamine D1 ligands

Sulfonamide-substituted indole modulators of RORC2 and methods of u...

Methyoxy-substituted pyrrolopyridine modulators of RORC2 and method...

Heteroarylphenoxy benzamide kappa opioid ligands

Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators...

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators...

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Fused pyridine compounds as casein kinase inhibitors

Patents Applicationslast 30 patents

AMINO-SUBSTITUTED HETEROCYCLES FOR TREATING CANCERS WITH EGFR MUTAT...

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS

AMINO-SUBSTITUTED HETEROCYCLES FOR TREATING CANCERS WITH EGFR MUTAT...

HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS

HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

RORC2 INHIBITORS AND METHODS OF USE THEREOF

Methyl- and Trifluromethyl-Substituted Pyrrolopyridine Modulators o...

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

Methyl- and Trifluromethyl-Substituted Pyrrolopyridine Modulators o...

RORC2 INHIBITORS AND METHODS OF USE THEREOF

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

RORC2 INHIBITORS AND METHODS OF USE THEREOF

Sulfonamide-Substituted Indole Modulators of RORC2 and Methods of U...

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

Methyl- and Trifluoromethyl-Substituted Pyrrolopyridine Modulators...

HETEROARYLPHENOXY BENZAMIDE KAPPA OPIOID LIGANDS

RORC2 INHIBITORS AND METHODS OF USE THEREOF

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

Methyoxy-Substituted Pyrrolopyridine Modulators of RORC2 and Method...

Methyl- and Trifluoromethyl-Substituted Pyrrolopyridine Modulators...

RORC2 INHIBITORS AND METHODS OF USE THEREOF

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS